A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction
Articolo
Data di Pubblicazione:
2003
Citazione:
A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction / D. Antoniucci, A. Rodriguez, A. Hempel, R. Valenti, A. Migliorini, F. Vigo, G. Parodi, C. Fernandez-Pereira, G. Moschi, A. Bartorelli, G. M. Santoro, L. Bolognese, A. Colombo. - In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. - ISSN 0735-1097. - 42:11(2003 Dec 03), pp. 1879-85-1885.
Abstract:
We sought to evaluate the efficacy of abciximab as adjunctive therapy to routine infarct-related artery (IRA) stenting.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Immunoglobulin Fab Fragments; Anticoagulants; Technetium Tc 99m Sestamibi; Humans; Aged; Coronary Restenosis; Antibodies, Monoclonal; Adult; Stents; Middle Aged; Myocardial Infarction; Chemotherapy, Adjuvant; Female; Male
Elenco autori:
D. Antoniucci, A. Rodriguez, A. Hempel, R. Valenti, A. Migliorini, F. Vigo, G. Parodi, C. Fernandez-Pereira, G. Moschi, A. Bartorelli, G. M. Santoro, L. Bolognese, A. Colombo
Link alla scheda completa: